What Buchler Gmbh does

Buchler GmbH is a German specialty chemicals manufacturer headquartered in Braunschweig that has produced natural extracts and chiral compounds since 1858 and operates as a member of the FAGUS Group under private limited liability (HRB 9223, Amtsgericht Braunschweig). The company develops, manufactures, and supplies Cinchona alkaloid-based products — including Cinchonine, Cinchonidine, Quinidine, and Cupreine Bases — as well as quinine-based Active Pharmaceutical Ingredients, food-grade ingredients (notably quinine for beverages such as tonic water and bitter liqueurs), and broader fine chemicals. Its portfolio is organized around three primary categories: Active Pharmaceutical Ingredients, Asymmetric Synthesis products (chiral building blocks, chiral phase transfer catalysts, a chiral screening kit, enantioselective organocatalysts, and racemic resolution agents), and Food Ingredients.

Buchler's underlying technology is asymmetric synthesis and chiral compound manufacturing based on Cinchona alkaloid-derived organocatalysts, delivering enantioselectivity up to 99% ee across more than 120 documented reaction types, including Michael additions, Mannich reactions, Henry reactions, Friedel-Crafts reactions, and the desymmetrization of prochiral cyclic anhydrides. The company's technical differentiators include its Cinchona Alkaloid Chemistry Platform — a comprehensive portfolio of natural and derivative alkaloids — and a free online Chiral Catalyst Search database that catalogs reaction examples with peer-reviewed literature citations, used both as an R&D tool for customers and as a lead-generation asset. Bulk manufacturing capacity of up to 1,000 kg for Quinidine Base and 100 kg for Cinchonine Base indicates industrial-scale production alongside R&D sample quantities of 1-10 g.

The business model is direct B2B sales to pharmaceutical manufacturers (primary segment), food and beverage producers, and fine chemical/research customers across global geographies. Revenue is generated through one-time sales of APIs and fine chemicals plus professional services in custom synthesis and racemic resolution. Distribution is via a company-owned e-commerce storefront for sample orders and quote-based direct sales for bulk contracts, with multi-year contracts on bulk shipments and free registration-based access to the chiral catalyst database. Two Managing Directors, Albrecht Perrin and Sebastian Lerg, oversee operations under German pharmaceutical and food regulatory supervision (Staatliches Gewerbeaufsichtsamt Braunschweig and Stadt Braunschweig Veterinärwesen und Verbraucherschutz).

Name

Buchler Gmbh

Legal name

BUCHLER GmbH

Website

https://buchler-gmbh.com

Company type

Private

Founded year

1858

Operating status

Operating

Short description

Buchler GmbH, founded 1858 in Braunschweig, Germany, and member of the FAGUS Group, manufactures Cinchona alkaloid-derived chiral catalysts, quinine-based APIs, and food ingredients for pharmaceutical, food and beverage, and fine chemical customers worldwide.

Ownership category

akta.pro rank

Headquarters

HQ city

Braunschweig

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Active Pharmaceutical Ingredients: Production and sale of APIs including quinine and quinine derivatives for pharmaceutical applications
2. Fine Chemicals - Chiral Building Blocks: Sale of fine chemicals including Cinchona alkaloids, chiral building blocks, and organocatalysts in various pack sizes from sample amounts (1g) to bulk quantities (1000kg)
3. Food Ingredients: Supply of food-grade ingredients including quinine for beverage and food applications
4. Custom Synthesis and Racemic Resolution Services: Chiral resolution services using Cinchona alkaloids as resolution agents for separation of enantiomers, supporting pharmaceutical API synthesis

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Buchler GmbH develops, manufactures, and supplies natural extracts and chiral compounds derived from Cinchona alkaloids, including quinine-based Active Pharmaceutical Ingredients (APIs), food-grade quinine ingredients for beverages, and a portfolio of fine chemicals such as Cinchonine Base, Quinidine Base, Cinchonidine Base, and Cupreine Base that serve as enantioselective organocatalysts and racemic resolution agents. The company sells in sample quantities (1g–10g) through its e-commerce storefront and in bulk (up to 1000kg) via direct quote-based sales to pharmaceutical, food and beverage, and fine chemical manufacturers.

Product overview

Buchler GmbH is a chemical manufacturing company specializing in natural extracts and chiral compounds since 1858, and is a member of the FAGUS Group. The company's product portfolio centers on Active Pharmaceutical Ingredients (APIs) and Food Ingredients, with a particular focus on Asymmetric Synthesis products. The core product offerings include fine chemicals based on Cinchona alkaloids such as Cinchonine Base, Quinidine Base, Cupreine Base, and Cinchonidine Base—these serve as enantioselective organocatalysts and racemic resolution agents for the pharmaceutical, agrochemical, and fine chemical industries. Supporting products include Chiral Building Blocks, Chiral Phase Transfer Catalysts (PTCs), Chiral Screening Kit, and Enantioselective Organocatalysts. The company also provides a Chiral Catalyst Search tool (a free database of reaction examples) as a resource for customers. The products relate as: APIs and Food Ingredients form the primary market segments, while the Asymmetric Synthesis product line (fine chemicals and specialized catalysts) serves as the technological foundation enabling these applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Cinchonine Base – Fine Chemical

Quantifiable outcome

• Up to 99% ee (enantiomeric excess) achievable in asymmetric reactions
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Fagus GroupparentOthersBuchler GmbH is a member of the Fagus Group. The Code of Conduct is published 'by BUCHLER GmbH a Member of the Fagus Group.' The parent company relationship provides organizational oversight and group-level governance for Buchler's operations.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Johnson Matthey: Global specialty chemicals and pharma services company with significant chiral catalysis capabilities (licensed and proprietary) plus large-scale API custom manufacturing. Much larger, more diversified, and offers overlapping capabilities as part of a broader fine chemicals and pharma services portfolio.
• Evonik: German specialty chemicals company with a healthcare division producing APIs, chiral intermediates, and fine chemicals for the same pharmaceutical customers as Buchler. Much larger and more diversified, with overlapping capabilities in chiral chemistry serving pharma.
• Cambrex: Pharmaceutical CDMO with API manufacturing capabilities including chiral APIs, serving similar global pharma customers. Larger-scale contract manufacturing focus, but competes directly for chiral API manufacturing programs that Buchler also targets.
• BASF: German chemical conglomerate with significant fine chemicals and pharma-related offerings including chiral intermediates, catalysts, and APIs. Overlaps with Buchler's customer base but operates at vastly larger scale across a much broader portfolio.

Direct peers

• Cayman Chemical: US-based fine-chemicals manufacturer serving research and pharma with chiral compounds, biochemicals, and reference standards. Directly comparable mid-size niche player using a similar e-commerce-plus-quote model for research-to-bulk supply.
• Strem Chemicals: US-based specialty chemicals manufacturer specializing in catalysts (including organocatalysts and chiral ligands) and research chemicals. Highly comparable niche: small catalog, high-purity specialty chemicals, academic and pharma research customers.
• Dishman Carbogen Amcis: India-based manufacturer focused on chiral APIs and intermediates for the pharmaceutical industry. Directly comparable business model (chiral chemistry + APIs for global pharma customers), differentiated by lower-cost manufacturing footprint.
• TCI Chemicals: Tokyo Chemical Industry is a global fine-chemicals manufacturer with a comparable research and catalog offering, including chiral catalysts and organocatalysts. Directly competes for the same research-customer wallet share at similar order sizes, with a stronger Asia-Pacific footprint.
• MilliporeSigma (Sigma-Aldrich): The dominant global fine-chemicals catalog supplier (Merck KGaA's life science arm) with a comparable chiral compounds and reagents offering across pharma, food, and research customers. Direct competitor in the catalog supply of Cinchona alkaloids and chiral building blocks, but at much larger scale and with a far broader portfolio.

Emerging players

• Codexis: Enzyme engineering company focused on biocatalysis for pharmaceutical synthesis — an alternative technology to Cinchona organocatalysis serving the same end-customer need for asymmetric synthesis. Smaller and earlier-stage, but represents a credible substitute path.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/BuchlerGmbh
• LinkedInlinkedin.com/company/buchler-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Buchler Gmbh